Article Type
Changed
Mon, 01/28/2019 - 14:35

Fitbit and sleep applications for smartphones should not be recommended as screening tools for obstructive sleep apnea. Also today, there is no evidence for the disease-modifying effect of levodopa in Parkinson’s Disease, and ablation surpassed drugs for raising quality of life for atrial fibrillation.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Sections

Fitbit and sleep applications for smartphones should not be recommended as screening tools for obstructive sleep apnea. Also today, there is no evidence for the disease-modifying effect of levodopa in Parkinson’s Disease, and ablation surpassed drugs for raising quality of life for atrial fibrillation.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Fitbit and sleep applications for smartphones should not be recommended as screening tools for obstructive sleep apnea. Also today, there is no evidence for the disease-modifying effect of levodopa in Parkinson’s Disease, and ablation surpassed drugs for raising quality of life for atrial fibrillation.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica